Genex Pharmaceutical Overview
Genex Pharmaceutical General Information
Description
Genex Pharmaceutical Inc is engaged in the production and distribution of Reconstituted Bone Xenograft (RBX) in the People's Republic of China.
Contact Information
Want to dig into this profile?
We’ll help you find what you need
Learn more
Genex Pharmaceutical Stock Performance
(As of Thursday Closing)
Stock Price |
Previous Close |
52 wk Range |
Market Cap |
Shares |
Average Volume |
EPS |
|
|
|
|
|
19.8K |
|
Genex Pharmaceutical Financials Summary
In Thousands, USD
|
TTM
31-Dec-2007
|
FY 2007
31-Dec-2007
|
FY 2006
31-Dec-2006
|
FY 2005
31-Dec-2005
|
EV |
4,745 |
4,745 |
1,880 |
1,861 |
Revenue |
3,237 |
3,237 |
2,438 |
2,491 |
EBITDA |
535 |
535 |
902 |
1,013 |
Net Income |
343 |
343 |
619 |
625 |
Total Assets |
8,649 |
8,649 |
5,745 |
4,422 |
Total Debt |
0 |
0 |
0 |
|
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Genex Pharmaceutical Signals
Growth Rate
0.80%
Weekly
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial